Buzin, C H; Tang, S H; Cunningham, J M et al. (2001) Low frequency of p53 gene mutations in breast cancers of Japanese-American women. Nutr Cancer 39:72-7
|
Blaszyk, H; Hartmann, A; Cunningham, J M et al. (2000) A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. Int J Cancer 89:32-8
|
Hartmann, A; Blaszyk, H; Kovach, J S et al. (1997) The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13:27-33
|
Hartmann, A; Blaszyk, H; Saitoh, S et al. (1996) High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population. Br J Cancer 73:896-901
|
Kovach, J S; Hartmann, A; Blaszyk, H et al. (1996) Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci U S A 93:1093-6
|
Blaszyk, H; Hartmann, A; Tamura, Y et al. (1996) Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations. Oncogene 13:2159-66
|
Hartmann, A; Blaszyk, H; McGovern, R M et al. (1995) p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 10:681-8
|
Hartmann, A; Rosanelli, G; Blaszyk, H et al. (1995) Novel pattern of P53 mutation in breast cancers from Austrian women. J Clin Invest 95:686-9
|
Blaszyk, H; Hartmann, A; Schroeder, J J et al. (1995) Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting. Biotechniques 18:256-60
|
Saitoh, S; Cunningham, J; De Vries, E M et al. (1994) p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. Oncogene 9:2869-75
|
Showing the most recent 10 out of 12 publications